1506 related articles for article (PubMed ID: 29947322)
1. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of a weight-loss Mediterranean diet/lifestyle intervention in the management of obstructive sleep apnea: Results of the "MIMOSA" randomized clinical trial.
Georgoulis M; Yiannakouris N; Kechribari I; Lamprou K; Perraki E; Vagiakis E; Kontogianni MD
Clin Nutr; 2021 Mar; 40(3):850-859. PubMed ID: 32928580
[TBL] [Abstract][Full Text] [Related]
3. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic Benefits of a Weight-Loss Mediterranean Diet/Lifestyle Intervention in Patients with Obstructive Sleep Apnea: The "MIMOSA" Randomized Clinical Trial.
Georgoulis M; Yiannakouris N; Kechribari I; Lamprou K; Perraki E; Vagiakis E; Kontogianni MD
Nutrients; 2020 May; 12(6):. PubMed ID: 32481487
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
[TBL] [Abstract][Full Text] [Related]
6. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
[TBL] [Abstract][Full Text] [Related]
7. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
Mazzotti A; Caletti MT; Brodosi L; Di Domizio S; Forchielli ML; Petta S; Bugianesi E; Bianchi G; Marchesini G
J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
Haigh L; Kirk C; El Gendy K; Gallacher J; Errington L; Mathers JC; Anstee QM
Clin Nutr; 2022 Sep; 41(9):1913-1931. PubMed ID: 35947894
[TBL] [Abstract][Full Text] [Related]
9. Sustained improvements in the cardiometabolic profile of patients with obstructive sleep apnea after a weight-loss Mediterranean diet/lifestyle intervention: 12-month follow-up (6 months post-intervention) of the "MIMOSA" randomized clinical trial.
Georgoulis M; Yiannakouris N; Kechribari I; Lamprou K; Perraki E; Vagiakis E; Kontogianni MD
Nutr Metab Cardiovasc Dis; 2023 May; 33(5):1019-1028. PubMed ID: 36958969
[TBL] [Abstract][Full Text] [Related]
10. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
[TBL] [Abstract][Full Text] [Related]
12. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
[TBL] [Abstract][Full Text] [Related]
13. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
Lim SL; Johal J; Ong KW; Han CY; Chan YH; Lee YM; Loo WM
JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14802. PubMed ID: 32281943
[TBL] [Abstract][Full Text] [Related]
14. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
Reinehr T; Schmidt C; Toschke AM; Andler W
Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
[TBL] [Abstract][Full Text] [Related]
16. [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial].
Dong C; Zhang CR; Xue BY; Miu WF; Fang NY; Li K; Ou ZJ; Xu YQ
Zhongguo Zhen Jiu; 2020 Feb; 40(2):129-34. PubMed ID: 32100496
[TBL] [Abstract][Full Text] [Related]
17. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
[TBL] [Abstract][Full Text] [Related]
18. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.
Hickman IJ; Jonsson JR; Prins JB; Ash S; Purdie DM; Clouston AD; Powell EE
Gut; 2004 Mar; 53(3):413-9. PubMed ID: 14960526
[TBL] [Abstract][Full Text] [Related]
19. The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes.
Naderpoor N; Mousa A; de Courten M; Scragg R; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():193-199. PubMed ID: 28899715
[TBL] [Abstract][Full Text] [Related]
20. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
